“…Invasive meningococcal disease (IMD) remains a significant global burden of disease, but the relative contribution of serogroups (sg) A, B, C, W, X, and Y have varied over time (Domingo et al, 2019;Hart and Thomson, 2006;Okike et al, 2014;Oordt-Speets et al, 2018). In recent years, several reports have shown increases of sg-W in carriers of Neisseria meningitidis and cases of IMD (Loenenbach et al, 2020;Booy et al, 2019;von Gottberg et al, 2008;Eriksson et al, 2018;Korzeniewski and Konior, 2018;Lucidarme et al, 2015;Carville et al, 2016;Neal et al, 2000;Ladhani et al, 2015;Meiring et al, 2019;Sáfadi et al, 2013;Abad et al, 2014;Constenla et al, 2015). For decades, B and C have been the dominant serogroups of disease in Europe, but a significant decline over the past 20 years has reduced the overall number of IMD cases (Purmohamad et al, 2019).…”